Together, we can connect patients with genetic testing

Sponsor a program and help patients get answers.

Contact Us

Find undiagnosed rare disease patients faster

Sponsor a program, get the data you need, and help patients get answers

Contact Us

Your patients are online, are you?

Digital Phenotyping

Identify thousands of undiagnosed rare disease patients with your target disease online within days

Expand your reach
Go beyond claims data and your KOLs to reach all patients, not just those on the right physician waitlists
Select the best patients for testing
Collect deep phenotypic data directly from patients and leverage our proprietary method to select the best patients for testing
Recruit patients earlier
Find patients earlier in their diagnostic odyssey and help them access clinical trials, treatments, or other resources
Sponsored testing programs 2.0

At-Home Genetic Testing

Test selected patients remotely and confirm diagnoses in as few as 8 weeks

Industry leading diagnostic yield
Direct-to-consumer telemedicine platform including WES, WGS, hexanucleotide repeat expansion testing, and more with up to a 55% diagnostic yield
CLIA-certified and CAP-accredited
Each test is performed in a CLIA-certified and CAP-accredited lab. All tests are ordered by a physician and include remote genetic counseling
Zero barrier to entry for patients
Patients receive the test at no charge and can complete the test without leaving their home or coordinating with a doctor’s office
Complement your claims data

Prevalence modeling

Predict the locations of undiagnosed patients for your target variant or phenotype

Prevalence estimates
Predict the total number of patients with a disease and break down estimates per genetic variant
Benchmarked against newborn screening
Proprietary method with close-to-newborn screening accuracy
Validated by experts
Peer-reviewed publication is in progress
55%
Superior diagnostic yield
12%
Varius enim in eros elementum tristique.
85%
Elementum tristique. Lorem ipsum dolor.

Check out one of our existing pharma partnerships

We’re helping a public drug developer find ultra rare mitochondrial disease patients

Check it out
Launch in less than 30 days

Check out one of our existing pharma partnerships

We’re helping a public drug developer find ultra rare mitochondrial disease patients.

Check it out